NCT07743320

Brief Summary

This trial aimed to evaluate the effectiveness of an AI-Powered Physician Assistant in improving patients' satisfaction with the quality of care. It also aims to evaluate physicians' satisfaction with the integration of a Physician Assistant into their clinical workflows. The primary research question is A. What is the effect of an AI-powered Physician Assistant on patients' satisfaction with their quality of care compared to the standard care? The secondary questions are as follows: B1. How satisfied are physicians with integrating an AI-powered physician assistant into their daily clinical workflows? B2. Which factors are significantly associated with patient satisfaction regarding the AI-Powered Physician Assistant? B3. Is there a statistically significant difference in mean consultation time per patient between those receiving AI-assisted care and those receiving only standard of careonly ? Participants will be enrolled from pre-operative outpatient clinics, including patients attending clinic for anaesthetic clearance prior to surgery and consultant anaesthetists providing care. Patients will serve as the unit of randomization and will be assigned to one of two study arms on each clinic day. On each clinic day, the first 8 eligible patients presenting for consultation will be randomly assigned to the intervention group or the control group in a 1:1 ratio. Intervention patients will proceed to a dedicated waiting room for structured digital intake via an AI platform (demographics, symptoms, history, clinical data) and receive AI-assisted care. Control group patients will undergo routine standard care protocols. The consultant physician will evaluate both arms during each clinic session, reviewing physician assistant-generated patient summaries and charts for patients in both the intervention and control groups. Each patient will be asked to fill out the survey at the end of the consultation with the physician. The consultants will be requested to fill out a survey at the end of the day.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
2mo left

Started Aug 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 28, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 3, 2026

Completed
27 days until next milestone

Study Start

First participant enrolled

August 30, 2026

Expected
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2026

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2026

Last Updated

August 3, 2026

Status Verified

July 1, 2026

Enrollment Period

2 months

First QC Date

July 28, 2026

Last Update Submit

July 31, 2026

Conditions

Keywords

Artificial IntelligencePatient SatisfactionQuality of CarePhysician SatisfactionWorkflow Efficiency

Outcome Measures

Primary Outcomes (1)

  • Patient Satisfaction and Outpatient Experience Score (Adapted NHS Outpatient Survey - Patient Questionnaire)

    Patient satisfaction will be evaluated across two domains: (1) effective utilization of waiting time and (2) receipt of patient-centered care during the outpatient visit. Evaluated post-consultation using a structured survey adapted from the NHS Outpatient Survey: Section A (Wait Time): Wait duration (A1) and wait time utility (A2). Section B (Doctor Interaction): Patient-centered care, consultation duration, listening, and clarity (B2-B7). Section C (AI Assistant - Intervention Arm Only): Perceived listening, trust, and privacy (C1-C6). Section D (Overall Impression): Respect, dignity, and care- quality (D1-D3). Ordinal items are assigned numerical scores to calculate a composite mean score and domain sub-scores (range: 1.0-5.0). Higher scores indicate greater satisfaction.

    From enrollment to the end of the study, for each patient, for 8 weeks

Secondary Outcomes (2)

  • Daily Physician Satisfaction and Workflow Efficiency Score (End-of-Day Physician Survey)

    From enrollment to the end of the study, for each physician, for 8 weeks

  • Total Physician Consultation Duration (Stopwatch Timestamps)

    From enrollment to the end of the study, for each patient, for 8 weeks

Other Outcomes (1)

  • Process flow evaluation outcome - Mean Queuing Time (Timestamp Tracking)

    From enrollment to the end of the study, for each patient, for 8 weeks

Study Arms (2)

AI-Assisted Care

EXPERIMENTAL

The patients in this arm will receive AI-assisted care in addition to the standard care. The AI platform will take the patient's history, and then the patient will talk to the consultant as part of the routine flow.

Other: AI-Powered Physicians' Assistant

Standard Care

NO INTERVENTION

The patients in this arm will receive standard care. The standard of care for our study is what is usually applied in Anaesthesiology outpatient clinics, with consultants seeing the patients after the resident.

Interventions

The study participant allocated to the intervention arm will interact with the AI-physician assistant application before they consult with the physician. The application will collect medical history of the patient. This will then be followed by an AI-generated clinical summary, which their physicians will receive before the consultation begins. Physicians will review this summary and ask further questions of patients if required. Any additions and changes in the patient's history will also be made. Physicians will subsequently conduct a physical examination of the patient. After this, the physician will be able to view AI- and guideline-based suggestions for the patient's assessment and pre-operative management. The recommendations can be selected, modified, or not used as per the physician's expertise. All additions within the application can be either typed manually or verbalised via an AI-assisted scribe within the application.

AI-Assisted Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Consent to participate
  • Age 18 years and above
  • Initial patients
  • Possession of a phone
  • Read and write Urdu and/or English

You may not qualify if:

  • Emergency Care patients
  • Follow-up patients
  • Physicians:
  • Attending or Consultant Physician
  • Consent to participate
  • Workflow integrated with AI Assistant
  • \- Residents and Senior Medical Officers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aga Khan University Hospital

Karachi, Sindh, 74800, Pakistan

Location

MeSH Terms

Conditions

Patient Satisfaction

Condition Hierarchy (Ancestors)

Treatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Dileep Kumar

    Aga Khan University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Shifa Habib

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Both the person allocating the patient to the intervention and control arms and the outcomes assessor will be masked
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor and Section Head

Study Record Dates

First Submitted

July 28, 2026

First Posted

August 3, 2026

Study Start (Estimated)

August 30, 2026

Primary Completion (Estimated)

October 30, 2026

Study Completion (Estimated)

October 30, 2026

Last Updated

August 3, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will share

The plan is to publish the study, and informed consent has been obtained from each participant. Each participant's data will be de-identified at the source level for both the application and survey.

Shared Documents
SAP, CSR
Access Criteria
Through Publication Only
More information

Locations